Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock : Design and rationale of CULPRIT-SHOCK trial

Publié dans American Heart Journal 2016 Feb;172:160-9 Auteurs : Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, de Waha S, Meyer-Saraei R, Schneider S, Windecker S, Savonitto S, Briggs A, Torremante P, Vrints C, Schuler G, Ceglarek U, Thiery J, Zeymer U; CULPRIT-SHOCK…

Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome

Publié dans Thrombosis and Haemostasis. 2016 Jan; 115(2):382-389 Auteurs : Collet JP, Kerneis M, Hulot JS, O'Connor SA, Silvain J, Mansencal N, Brugier D, Abtan J, Barthélémy O, Vignalou JB, Payot L, Rousseau H, Vicaut E, Montalescot G; GAMMA Investigators. Article disponible en consultant le site Abstract Abstract : Our aim was to demonstrate that…

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Publié dans American Heart Journal. 2015 Dec; 170(6):1061-1069 Auteurs : Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Article disponible en consultant le site Abstract Background and aim :…